More and more people buy the so-called urinary antispasmodics for treatment of overactive bladder. In four years, consumption has increased by 58.6 percent from 19,476 persons in 2001 to 30,899 in 2005. The increased consumption of this type of medicinal products is specifically centred on the more expensive products, which has lead to a considerable increase in the sale of these products. In 2005, the sale of urinary antispasmodics accounted for DKK 100 million.
We have examined whether this considerable increase in consumption of urinary antispasmodics is caused by a general increase in the number of users and/or an increase in the number of persons who buy the product over a long period of time. In addition, we have examined whether the increase is a result of a growing population of senior citizens and more people with diseases that may trigger overactive bladder. Study the results of the analysis:
Increase in consumption of urinary antispasmodics
